Psychedelic drug market to reach $7.2 bn in 2029: GlobalData
This ascent is propelled by favorable regulatory developments, including pioneering clinical trial guidelines from the FDA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
treatment-resistant depression
US FDA approves SPRAVATO, antidepressant medication from J&J
The drug indicated to treat adults with major depressive disorder and acute suicidal ideation or behaviour reportedly begins…